Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.
about
Factors associated with remaining on initial randomized efavirenz-containing regimens.Global HIV/AIDS Clinical and Translational PharmacologyPharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications.
P2860
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Therapeutic drug monitoring of ...... e substance-related disorders.
@ast
Therapeutic drug monitoring of ...... e substance-related disorders.
@en
type
label
Therapeutic drug monitoring of ...... e substance-related disorders.
@ast
Therapeutic drug monitoring of ...... e substance-related disorders.
@en
prefLabel
Therapeutic drug monitoring of ...... e substance-related disorders.
@ast
Therapeutic drug monitoring of ...... e substance-related disorders.
@en
P2093
P2860
P1476
Therapeutic drug monitoring of ...... ve substance-related disorders
@en
P2093
Alan Forrest
Amneris E Luque
Barbara M Gripshover
Barry S Zingman
Charles S Venuto
Gene D Morse
Margaret A Fischl
Robin DiFrancesco
P2860
P304
P356
10.1097/FTD.0B013E31821D3ADB
P50
P577
2011-06-01T00:00:00Z